Skip to main content
Market intelligence
GILDHealthcare

Gilead Sciences, Inc. insider activity

In the last 90 days, no corporate insiders reported open-market purchases.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Aug 3, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Aug 3, 2026Daniel Patrick O'DayChairman & CEOSale15,000$130.31$1,954,694
Jul 15, 2026Johanna MercierChief Comm & Corp Aff OfficerSale3,000$129.92$389,758
Jul 15, 2026Andrew D DickinsonChief Financial OfficerSale3,000$129.93$389,777